Citation Impact
Citing Papers
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Association Between Bicuspid Aortic Valve Phenotype and Patterns of Valvular Dysfunction and Bicuspid Aortopathy
2013
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus ‘conventional’ protective ventilation (6 ml/kg) in severe ARDS
2013
No health without mental health
2007 Standout
The Metabolic Syndrome and Inflammation
2004
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy
2001 StandoutNobel
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
2013
Effects of Indapamide in Rats with Pressure Overload Left Ventricular Hypertrophy
2000
Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
2002 Standout
Perceived discrimination and health: A meta-analytic review.
2009 Standout
The metabolic syndrome
2010 Standout
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
2005 Standout
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
Atherosclerosis: current pathogenesis and therapeutic options
2011 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 StandoutNobel
Inflammatory Biomarkers, Hormone Replacement Therapy, and Incident Coronary Heart Disease
2002
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
2002 Standout
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
2003 Standout
Cardiac troponin level elevations not related to acute coronary syndromes
2013
Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)–Added trial
2006
Interleukin-6 (IL-6) Induces Insulin Resistance in 3T3-L1 Adipocytes and Is, Like IL-8 and Tumor Necrosis Factor-α, Overexpressed in Human Fat Cells from Insulin-resistant Subjects
2003
Symptomatic improvement and reduced hospitalization for patients attending a cardiomyopathy clinic
1997
The metabolic syndrome
2005 Standout
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Comprehensive Discharge Planning and Home Follow-up of Hospitalized Elders
1999 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Effectiveness of Statin Therapy in Adults With Coronary Heart Disease
2004
Low-dose enoximone improves exercise capacity in chronic heart failure∗∗A list of the Enoximone Study Group Members and institutional affiliations is provided in the appendix.
2000
Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial
2007
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease
2004 Standout
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
2001 Standout
Effect of a Mediterranean-Style Diet on Endothelial Dysfunction and Markers of Vascular Inflammation in the Metabolic Syndrome
2004 Standout
Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure
1996
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve–related aortopathy: Full online-only version
2018
Appropriate prescribing in elderly people: how well can it be measured and optimised?
2007 Standout
Effects of HMG-CoA reductase inhibitors on continuous post-inflammatory vascular remodeling late after Kawasaki disease
2010
Ventilator-Induced Lung Injury
2013 Standout
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
1997 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Cardiovascular Reactivity and Development of Preclinical and Clinical Disease States
2003
Statin-Associated Myopathy
2003
Sex differences in immune responses
2016 Standout
Common Genetic Vulnerability to Depressive Symptoms and Coronary Artery Disease: A Review and Development of Candidate Genes Related to Inflammation and Serotonin
2006
Underutilisation of ACE Inhibitors in Patients with Congestive Heart Failure
2001
Genetics of myocardial infarction: a progress report
2010
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Sex hormones and the immune response in humans
2005
Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: symptomatic cardiac obstruction–pilot study of enalapril in aortic stenosis (SCOPE-AS)
2004
Fortnightly Review: Diagnosis and management of heart failure
1994
Adipose Tissue as an Endocrine Organ
2004 Standout
What is the ideal study design for evaluation of treatment for heart failure?: Insights from trials assessing the effect of ACE inhibitors on exercise capacity
1996
The Complex Role of Estrogens in Inflammation
2007 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Blockade of the Renin-Angiotensin System in Cardiac Pressure-Overload Hypertrophy in Rats
1995
Markers of Inflammation and Cardiovascular Disease
2003 Standout
Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure
1999 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Overexpression of angiotensin AT 1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block
1997 StandoutNobel
Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure
2009 Standout
Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention
2003 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
2003
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Narrative Review: Pharmacotherapy for Chronic Heart Failure: Evidence from Recent Clinical Trials
2005
Ischemic Mitral Regurgitation on the Threshold of a Solution
2005
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
A systematic review and economic evaluation of statins for the prevention of coronary events
2007
The Metabolic Syndrome
2008 Standout
Inflammatory Markers and Onset of Cardiovascular Events
2003 Standout
Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice?
1996
Absolute and Attributable Risks of Atrial Fibrillation in Relation to Optimal and Borderline Risk Factors
2011
Improvement in Exercise Tolerance and Symptoms of Congestive Heart Failure During Treatment With Candesartan Cilexetil
1999
Losartan in Heart Failure
1995
Hepatic Acetyl CoA Links Adipose Tissue Inflammation to Hepatic Insulin Resistance and Type 2 Diabetes
2015
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation
2009
Works of G. Riegger being referenced
Hormone Replacement Therapy and Interrelation between Serum Interleukin-6 and Body Mass Index in Postmenopausal Women: A Population-Based Study
2000
Variable phenotypes of bicuspid aortic valve disease: classification by cardiovascular magnetic resonance
2010
High-sensitive Troponin I in acute cardiac conditions: Implications of baseline and sequential measurements for diagnosis of myocardial infarction
2012
No association of interleukin-6 gene polymorphism (−174 G/C) with myocardial infarction or traditional cardiovascular risk factors
2004
Autoregulation of ventilation with neurally adjusted ventilatory assist on extracorporeal lung support
2010
Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure
1991
Role of Neurohumoral Systems for Pressure Induced Left Ventricular Hypertrophy in Experimental Supravalvular Aortic Stenosis in Rats
1991
Failure to achieve recommended LDL cholesterol levels by suboptimal statin therapy relates to elevated cardiac event rates
2005
The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatment
1999
The Benefits of Early Combination Treatment of Carvedilol and an ACE-Inhibitor in Mild Heart Failure and Left Ventricular Systolic Dysfunction. The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure Evaluation Trial (CARMEN)
2004
Prostaglandin I2 Versus Prostaglandin E2 in Dogs With and Without Low Cardiac Output: Differential Effects on Renal Function
1992
Distinct Heritable Patterns of Angiographic Coronary Artery Disease in Families With Myocardial Infarction
2005
Genetic Variants Within the LPIN1 Gene, Encoding Lipin, Are Influencing Phenotypes of the Metabolic Syndrome in Humans
2007